Oncocore for Cancer Patients
Providing Insights to Cancer Patients & Generating Real World Evidence
Clinical Responder Analysis
Applying Real World Evidence to Clinical Development & Outcomes research
Discovering Novel Drug Combinations within Pharma Pipelines
Prioritizing Novel Indications for Approved & Pipeline Drugs
BioXplor has developed a proprietary cancer data analytics platform to collect real world evidence and combine it with our biomedical knowledge engine via a suite of tools and algorithms that generates advanced insights for clinical development and outcomes research.
Clinical Development & Outcomes Research
Patient Consent to Collect & Analyse Medical Records & Tumor Genomics Data
Find Clinical Trials Matched to Patient's Medical Records & Genomics Data
Find insights on Treatments based on Tumor Mutations
Find Clinicians for Second Opinions, and Enable Sharing of Medical Records
Find Insights on Side Effects Related to Drugs and Treatments for Side Effects
Access to Medical Research Literature and Clinical Trials Reports
ONCOCORE helps cancer patients to find the right clinical trials and insights into tumor mutations and treatments, find medical oncologists for second opinions, and support medical research to find the cures for tomorrow by improving outcomes for those cancer patients enrolling in clinical trials today.
From Our Company
FORBES lists BioXplor Cofounder Anna O'LEary
52 Women-Led Startups Driving The Future Of HealthTech And FemTech
StartUp Health Article on BioXplor
Meet BioXplor, the Startup Speeding Up Novel Drug Combination Discovery Through Smarter Data Analysis
BioXplor wins EIT Health-Amgen Challenge
BioXplor is the winner of the EIT Health-Amgen Challenge to ‘Identify the Right Treatment for the Right Patient in Multiple Myeloma’ as judged by the innovation managers from Takeda, Sanofi, Abbott and AstraZeneca.
Watch (1 min)